US Recall News

United States Recall News Alerts for Recalled Drugs, Food, Products, & Vehicles

MENUMENU
  • Home
  • About
    • Advertise
  • Full Recall News Archive
    • Top Story

      J&J Settles Talc Mesothelioma Settlement

      By Sandra Dalton, Staff Writer On January 6, 2020, Superior Court Judge Stephen Kaus announced that Johnson & Johnsons (J&J) had agreed to … [Read More...]

      Salento Organics Issues Allergy Alert on Undeclared Milk in Dark Chocolate Fruit and Peanut Bites

      Summary Company Announcement Date: March 29, 2023 FDA Publish Date: … [Read More...]

    • More Safety Articles
    • Federal Preemption of State Product Liability Law
  • Drug Recalls
    • Abilify
    • Benicar
    • Fluoroquinolones
    • Invokana
    • Lipitor
    • Nuplazid
    • Opioids
    • OxyContin
    • Pradaxa
    • Proton Pump Inhibitors (PPIs)
    • Risperdal
    • SSRI
    • Symptoms & Side Effects
    • Taxotere
    • Testosterone
    • Uloric
    • Valsartan
    • Xarelto
    • Zofran
  • Medical Devices
    • 3M Earplug
    • 3T Heater-Cooler System
    • Bair Hugger
    • Bipolar Hip System
    • Essure
    • Hip Replacements
    • Implanon
    • IVC Filters
    • Hernia Mesh
    • Power Morcellators
    • Shoulder Implants
    • Transvaginal Mesh
  • Food Recalls
    • FDA Press Releases
    • USDA Press Releases
  • Auto Recalls
    • Air Bags
    • Ignitions
    • NHTSA Press Releases
    • Off-Road Utility Vehicles
    • Snowmobiles
    • Tires
  • Other Products
    • Asbestos
    • Baby Products
    • Pet Products
    • Roundup
    • Talcum Powder
    • Toy Recalls
You are here: Home / Food Recalls / FDA Press Releases / UPDATED: Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Valsartan/Amlodipine/HCTZ, Valsartan/Amlodipine and Valsartan Tablets

UPDATED: Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Valsartan/Amlodipine/HCTZ, Valsartan/Amlodipine and Valsartan Tablets

August 21, 2018 By The FDA Leave a Comment

NDC 13668-325-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets BBX2D025 Nov-2019 NDC 13668-325-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets BBX2D026 Nov-2019 NDC 13668-325-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets BBX2E001 Jan-2020 NDC 13668-325-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets BBX2E002 Jan-2020 NDC 13668-325-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets BBX2E003 Jan-2020 NDC 13668-325-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets BBX2E004 Jan-2020 NDC 13668-325-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets BBX2E005 Jan-2020 NDC 13668-328-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/160mg/25mg, 30 Tablets BBX9D004 Nov-2019 NDC 13668-328-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/160mg/25mg, 30 Tablets BBX9E001 Jan-2020 NDC 13668-326-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 5mg/160mg/12.5mg, 30 Tablets BBY1E001 Dec-2019 NDC 13668-326-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 5mg/160mg/12.5mg, 30 Tablets BBY1E003 Mar-2020 NDC 13668-327-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/160mg/12.5mg, 30 Tablets BBY2E001 Mar-2020 NDC 13668-329-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 5mg/160mg/25mg, 30 Tablets BBY4D004 Nov-2019 NDC 13668-329-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 5mg/160mg/25mg, 30 Tablets BBY4E001 Jan-2020 NDC 13668-329-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 5mg/160mg/25mg, 30 Tablets BBY4E001 Jan-2020 NDC 13668-325-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets BBX2D003 Mar-2019 NDC 13668-325-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets BBX2D004 Mar-2019 NDC 13668-325-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets BBX2D005 Mar-2019 NDC 13668-325-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets BBX2D006 Mar-2019 NDC 13668-325-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets BBX2D007 Mar-2019 NDC 13668-325-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets BBX2D008 Mar-2019 NDC 13668-325-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets BBX2D015 Oct 2019 NDC 13668-325-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets BBX2D016 Oct 2019 NDC 13668-325-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets BBX2D017 Oct 2019 NDC 13668-325-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets BBX2D018 Oct 2019 NDC 13668-325-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets BBX2D019 Oct 2019 NDC 13668-325-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets BBX2D020 Oct 2019 NDC 13668-325-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets BBX2D021 Oct 2019 NDC 13668-325-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets BBX2D022 Oct 2019 NDC 13668-325-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets BBX2D024 Nov 2019 NDC 13668-328-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/160mg/25mg, 30 Tablets BBX9D001 Feb 2019 NDC 13668-326-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 5mg/160mg/12.5mg, 30 Tablets BBY1C002 Sep 2018 NDC 13668-326-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 5mg/160mg/12.5mg, 30 Tablets BBY1E002 Mar-2020 NDC 13668-326-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/160mg/12.5mg, 30 Tablets BBY2D001 Feb 2019 NDC 13668-326-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/160mg/12.5mg, 30 Tablets BBY2D002 Nov 2019 NDC 13668-207-30 Amlodipine and Valsartan Tablets 5 mg/160 mg, USP, 30 Tablets BV53D004 Oct 2019 NDC 13668-206-30 Amlodipine and Valsartan Tablets 10 mg/160 mg, USP, 30 Tablets BV65D002 Oct 2019 NDC 13668-204-30 Amlodipine and Valsartan Tablets 10 mg/320 mg, USP, 30 Tablets BV77D013 Oct 2019 NDC 13668-205-30 Amlodipine and Valsartan Tablets 5 mg/320 mg, USP, 30 Tablets BV84D010 Oct 2019 NDC 13668-205-30 Amlodipine and Valsartan Tablets 5 mg/320 mg, USP, 30 Tablets BV84E001 Dec 2019 NDC 13668-325-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets BBX2D001 Dec 2018 NDC 13668-325-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets BBX2D002 Dec 2018 NDC 13668-325-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets BBX2D009 Mar 2019 NDC 13668-325-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets BBX2D010 Apr 2019 NDC 13668-325-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets BBX2D011 Apr 2019 NDC 13668-325-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets BBX2D012 May 2019 NDC 13668-325-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets BBX2D013 May 2019 NDC 13668-325-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets BBX2D014 Aug 2019 NDC 13668-328-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/160mg/25mg, 30 Tablets BBX9D002 Mar 2019 NDC 13668-328-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/160mg/25mg, 30 Tablets BBX9D003 Jul 2019 NDC 13668-326-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 5mg/160mg/12.5mg, 30 Tablets BBY1D001 May 2019 NDC 13668-329-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 5mg/160mg/25mg, 30 Tablets BBY4D001 Apr 2019 NDC 13668-329-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 5mg/160mg/25mg, 30 Tablets BBY4D002 Apr 2019 NDC 13668-329-30 Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 5mg/160mg/25mg, 30 Tablets BBY4D003 Jun 2019 NDC 13668-068-90 Valsartan Tablets, USP, 80 mg, 90 Tablets BV46C007 Sept 2018 NDC 13668-068-90 Valsartan Tablets, USP, 80 mg, 90 Tablets BV46C008 Oct 2018 NDC 13668-068-90 Valsartan Tablets, USP, 80 mg, 90 Tablets BV46C009 Oct 2018 NDC 13668-068-90 Valsartan Tablets, USP, 80 mg, 90 Tablets BV46C010 Oct 2018 NDC 13668-068-90 Valsartan Tablets, USP, 80 mg, 90 Tablets BV46C011 Nov 2018 NDC 13668-068-90 Valsartan Tablets, USP, 80 mg, 90 Tablets BV46C012 Nov 2018 NDC 13668-069-90 Valsartan Tablets, USP,160 mg, 90 Tablets BV47C005 Sep 2018 NDC 13668-069-90 Valsartan Tablets, USP, 160 mg, 90 Tablets BV47C006 Sept 2018 NDC 13668-069-90 Valsartan Tablets, USP, 160 mg, 90 Tablets BV47D001 Dec 2018 NDC 13668-070-90 Valsartan Tablets, USP, 320 mg, 90 Tablets BV48D001 Dec 2018 NDC 13668-070-90 Valsartan Tablets, USP, 320 mg, 90 Tablets BV48D002 Dec 2018 NDC 13668-207-30 Amlodipine and Valsartan Tablets 5 mg/160 mg, USP, 30 Tablets BV53C006 Nov 2018 NDC 13668-207-30 Amlodipine and Valsartan Tablets 5 mg/160 mg, USP, 30 Tablets BV53D001 Feb 2019 NDC 13668-207-30 Amlodipine and Valsartan Tablets 5 mg/160 mg, USP, 30 Tablets BV53D002 Feb 2019 NDC 13668-207-30 Amlodipine and Valsartan Tablets 5 mg/160 mg, USP, 30 Tablets BV53D003 Sep 2019 NDC 13668-206-30 Amlodipine and Valsartan Tablets 10 mg/160 mg, USP, 30 Tablets BV65C002 Sep 2018 NDC 13668-206-30 Amlodipine and Valsartan Tablets 10 mg/160 mg, USP, 30 Tablets BV65C003 Oct 2018 NDC 13668-206-30 Amlodipine and Valsartan Tablets 10 mg/160 mg, USP, 30 Tablets BV65C004 Nov 2018 NDC 13668-206-30 Amlodipine and Valsartan Tablets 10 mg/160 mg, USP, 30 Tablets BV65D001 Aug 2019 NDC 13668-204-30 Amlodipine and Valsartan Tablets 10 mg/320 mg, USP, 30 Tablets BV77C001 Oct 2018 NDC 13668-204-30 Amlodipine and Valsartan Tablets 10 mg/320 mg, USP, 30 Tablets BV77D001 Feb 2019 NDC 13668-204-30 Amlodipine and Valsartan Tablets 10 mg/320 mg, USP, 30 Tablets BV77D002 Feb 2019 NDC 13668-204-30 Amlodipine and Valsartan Tablets 10 mg/320 mg, USP, 30 Tablets BV77D003 Feb 2019 NDC 13668-204-30 Amlodipine and Valsartan Tablets 10 mg/320 mg, USP, 30 Tablets BV77D004 Feb 2019 NDC 13668-204-30 Amlodipine and Valsartan Tablets 10 mg/320 mg, USP, 30 Tablets BV77D005 Feb 2019 NDC 13668-204-30 Amlodipine and Valsartan Tablets 10 mg/320 mg, USP, 30 Tablets BV77D006 Feb 2019 NDC 13668-204-30 Amlodipine and Valsartan Tablets 10 mg/320 mg, USP, 30 Tablets BV77D007 Feb 2019 NDC 13668-204-30 Amlodipine and Valsartan Tablets 10 mg/320 mg, USP, 30 Tablets BV77D008 May 2019 NDC 13668-204-30 Amlodipine and Valsartan Tablets 10 mg/320 mg, USP, 30 Tablets BV77D009 Aug 2019 NDC 13668-204-30 Amlodipine and Valsartan Tablets 10 mg/320 mg, USP, 30 Tablets BV77D010 Sep 2019 NDC 13668-204-30 Amlodipine and Valsartan Tablets 10 mg/320 mg, USP, 30 Tablets BV77D011 Sep 2019 NDC 13668-204-30 Amlodipine and Valsartan Tablets 10 mg/320 mg, USP, 30 Tablets BV77D012 Sep 2019 NDC 13668-205-30 Amlodipine and Valsartan Tablets 5 mg/320 mg, USP, 30 Tablets BV84C011 Oct 2018 NDC 13668-205-30 Amlodipine and Valsartan Tablets 5 mg/320 mg, USP, 30 Tablets BV84D001 Jan 2019 NDC 13668-205-30 Amlodipine and Valsartan Tablets 5 mg/320 mg, USP, 30 Tablets BV84D002 Jan 2019 NDC 13668-205-30 Amlodipine and Valsartan Tablets 5 mg/320 mg, USP, 30 Tablets BV84D005 Feb 2019 NDC 13668-205-30 Amlodipine and Valsartan Tablets 5 mg/320 mg, USP, 30 Tablets BV84D006 Feb 2019 NDC 13668-205-30 Amlodipine and Valsartan Tablets 5 mg/320 mg, USP, 30 Tablets BV84D007 Feb 2019 NDC 13668-205-30 Amlodipine and Valsartan Tablets 5 mg/320 mg, USP, 30 Tablets BV84D008 May 2019 NDC 13668-205-30 Amlodipine and Valsartan Tablets 5 mg/320 mg, USP, 30 Tablets BV84D009 May 2019

Share this:

  • Facebook
  • Twitter
  • LinkedIn
  • Email
  • Print

Related

Filed Under: FDA Press Releases

About The FDA

The Food and Drug Administration (FDA) is an agency within the U.S. Department of Health and Human Services. It consists of the Office of the Commissioner and four directorates overseeing the core functions of the agency: Medical Products and Tobacco, Foods and Veterinary Medicine, Global Regulatory Operations and Policy, and Operations.

Leave a Reply Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Facebook
Thomas Roney LLC
Economic Consulting

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Salento Organics Issues Allergy Alert on Undeclared Milk in Dark Chocolate Fruit and Peanut Bites

March 29, 2023 By The FDA

North American Food Distributing Company, Inc. Issues Allergy Alert on Undeclared Soy in 16.9 Fl Oz of Kagome Worcester Sauce and 16.9 Fl Oz of Kagome Chuno Sauce

March 27, 2023 By The FDA

Gilster-Mary Lee Corp. Issues a Recall for Undeclared Milk Allergen in HyVee Hamburger Chili Macaroni Skillet Meal

March 27, 2023 By The FDA

Hero Highlight

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Kawasaki Motors USA Recalls Engines Sold on Ferris and SCAG Riding Lawn Mowers Due to Burn and Fire Hazards

March 22, 2023 By The CPSC

Burnham Commercial Recalls Natural Gas Boilers Due to Burn Hazard (Recall Alert)

March 22, 2023 By The CPSC

Textron Specialized Vehicles Recalls Arctic Cat Alterra 600 and
Tracker 600 All-Terrain Vehicles (ATVs) Due to Crash Hazard
(Recall Alert)

March 22, 2023 By The CPSC

Ascend Laboratories LLC. Issues Voluntary Nationwide Recall of Dabigatran Etexilate Capsules, USP 75 mg and 150 mg, Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity

March 21, 2023 By The FDA

Perfection Bakeries, d/b/a/ Aunt Millie’s Issues Allergy Alert on Undeclared Sesame in “Our Family Hot Dog Buns 8 Ct.”

March 21, 2023 By The FDA

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Ascend Laboratories LLC. Issues Voluntary Nationwide Recall of Dabigatran Etexilate Capsules, USP 75 mg and 150 mg, Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity

March 21, 2023 By The FDA

Perfection Bakeries, d/b/a/ Aunt Millie’s Issues Allergy Alert on Undeclared Sesame in “Our Family Hot Dog Buns 8 Ct.”

March 21, 2023 By The FDA

Mutual Trading Co., Inc Issues Allergy Alert for Undeclared Soy in Sauces

March 20, 2023 By The FDA

Recall News in Your Inbox

Enter your email address to receive automated recall news updates.

Recent Comments

  • Roger McGowan on ABH NATURE’S PRODUCTS, INC, ABH PHARMA, INC., and STOCKNUTRA.COM, INC. Issues Nationwide Recall of All Lots of Dietary Supplement Products
  • Kathryn Moore on FDA Wants Cancer Warning on Breast Implants
  • BRAD on Huge ATV Recall by Polaris – Sportsman and Scrambler
  • Crystal Anderson on Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders
  • Outsourcing Training on The Modern Marketing of Pain
  • SANDRA Collett on Processed Food Preservative Linked to Autism?
  • Eric Karsh on Health Risks of Roundup Go Well Beyond Cancer

Recent Posts

  • Salento Organics Issues Allergy Alert on Undeclared Milk in Dark Chocolate Fruit and Peanut Bites
  • North American Food Distributing Company, Inc. Issues Allergy Alert on Undeclared Soy in 16.9 Fl Oz of Kagome Worcester Sauce and 16.9 Fl Oz of Kagome Chuno Sauce
  • Gilster-Mary Lee Corp. Issues a Recall for Undeclared Milk Allergen in HyVee Hamburger Chili Macaroni Skillet Meal
  • Jarman’s Midwest Cleaning Systems, Inc. Issues Voluntary Nationwide Recall of Alcohol Antiseptic 80% Topical Solution Hand Sanitizer Non-sterile Solution and Isopropyl Alcohol Antiseptic 75% Topical Solution Hand Sanitizer Non-sterile Solution Due to Presence of Methanol
  • Second Nature Brands Issues Allergy Alert on Undeclared Wheat in Gluten Free Reese’s Pieces Brownie Brittle
  • Kawasaki Motors USA Recalls Engines Sold on Ferris and SCAG Riding Lawn Mowers Due to Burn and Fire Hazards
  • Burnham Commercial Recalls Natural Gas Boilers Due to Burn Hazard (Recall Alert)
  • Textron Specialized Vehicles Recalls Arctic Cat Alterra 600 and
    Tracker 600 All-Terrain Vehicles (ATVs) Due to Crash Hazard
    (Recall Alert)
  • Ascend Laboratories LLC. Issues Voluntary Nationwide Recall of Dabigatran Etexilate Capsules, USP 75 mg and 150 mg, Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity
-- See More Recall News

Disclaimer: The information contained in these topics is not intended nor implied to be a substitute for professional medical or legal advice, it is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider about any questions you may have regarding a medical condition. Nothing contained in these topics is intended to be used for medical diagnosis or treatment.


ATTORNEY ADVERTISING. The information provided on this website is not legal advice. No attorney-client relationship is formed by the use of this site. It is not stated or implied that a lawyer is certified as a specialist in any particular field of law. No results are guaranteed, and prior results do not guarantee a similar outcome. This site is informational, only, not dispositive; it is up to you to decide whether a particular lawyer is right for you. Use of this site is subject to your agreement to these.


Copyright © 2023 Altrumedia · Terms of Service · Log in